PAPER Sadowski MJ
SEARCH RESULTS
329930 RESULTS
PAPER
Upcoming meetings related to Alzheimer's disease.
Rev Neurol. 2010 Mar 16;50(6):349-59. PubMed: 20308794PAPER Schork NJ, Topol EJ
Genotype-based risk and pharmacogenetic sampling in clinical trials.
J Biopharm Stat. 2010 Mar;20(2):315-33. PubMed: 20309761PAPER Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A
Association between cognition and function in patients with Parkinson disease with and without dementia.
Mov Disord. 2010 Mar 22; PubMed: 20310053PAPER Sadowsky C, Perez JA, Bouchard RW, Goodman I, Tekin S
Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.
CNS Neurosci Ther. 2010 Spring;16(1):51-60. PubMed: 20070789PAPER Miller KG
Long-term care: facility quality and safety. Issue brief.
Issue Brief Health Policy Track Serv. 2010 Jan 4;:1-42. PubMed: 20217926PAPER Wilson RS, Aggarwal NT, Barnes LL, Mendes de Leon CF, Hebert LE, Evans DA
Cognitive decline in incident Alzheimer disease in a community population.
Neurology. 2010 Mar 23;74(12):951-5. PubMed: 20308679PAPER Dance A, Landhuis E, Strobel G
The society for neuroscience 2009 meeting report, part 2.
J Alzheimers Dis. 2010 Jan 1;19(4):1409-15. PubMed: 20308793PAPER Rabe M, Felbecker A, Waibel S, Steinbach P, Winter P, Ludolph AC
The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families.
J Neurol. 2010 Mar 23; PubMed: 20309572PAPER Schneider SA, Paisan-Ruiz C, Quinn NP, Lees AJ, Houlden H, Hardy J, Bhatia KP
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
Mov Disord. 2010 Jun 15;25(8):979-84. PubMed: 20310007PAPER Gagne JJ, Power MC
Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.
Neurology. 2010 Mar 23;74(12):995-1002. PubMed: 20308684PAPER Comi C, Carecchio M, Chiocchetti A, Nicola S, Galimberti D, Fenoglio C, Cappellano G, Monaco F, Scarpini E, Dianzani U
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.
J Alzheimers Dis. 2010;19(4):1143-8. PubMed: 20308780PAPER Cook NL, Vink R, Helps SC, Manavis J, van den Heuvel C
Transient Receptor Potential Melastatin 2 Expression is Increased Following Experimental Traumatic Brain Injury in Rats.
J Mol Neurosci. 2010 Mar 23; PubMed: 20309649PAPER Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB
The neuroinflammatory hypothesis of delirium.
Acta Neuropathol. 2010 Jun;119(6):737-54. PubMed: 20309566PAPER Zhang GR, Geller AI
A helper virus-free HSV-1 vector containing the vesicular glutamate transporter-1 promoter supports expression preferentially in VGLUT1-containing glutamatergic neurons.
Brain Res. 2010 May 17;1331:12-9. PubMed: 20307509Current Filters
No filters selected